Diana DeGette

DeOndra Dixon INCLUDE Project Act of 2025

Medicare Advantage Cost Transparency Act

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.

Colorado Wilderness Act of 2026

Follow the Science Act

Fracturing Responsibility and Awareness of Chemicals Act of 2025

Physical Therapist Workforce and Patient Access Act of 2025